Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Return on Assets (2016 - 2025)

Historic Return on Assets for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to 0.15%.

  • Novartis Ag's Return on Assets rose 200.0% to 0.15% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.15%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.13% for FY2025, which is 100.0% up from last year.
  • Novartis Ag's Return on Assets amounted to 0.15% in Q4 2025, which was up 200.0% from 0.16% recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Return on Assets registered a high of 0.21% during Q4 2021, and its lowest value of 0.01% during Q2 2023.
  • Over the past 5 years, Novartis Ag's median Return on Assets value was 0.13% (recorded in 2024), while the average stood at 0.12%.
  • As far as peak fluctuations go, Novartis Ag's Return on Assets plummeted by -2000bps in 2023, and later skyrocketed by 1600bps in 2024.
  • Novartis Ag's Return on Assets (Quarter) stood at 0.21% in 2021, then plummeted by -79bps to 0.04% in 2022, then surged by 36bps to 0.06% in 2023, then surged by 124bps to 0.13% in 2024, then grew by 13bps to 0.15% in 2025.
  • Its Return on Assets was 0.15% in Q4 2025, compared to 0.16% in Q3 2025 and 0.15% in Q2 2025.